Working… Menu
Help guide our efforts to modernize
Send us your comments by March 14, 2020.

Fludeoxyglucose F 18 Positron Emission Tomography in Predicting Risk of Relapse in Patients With Non-Hodgkin's Lymphoma Who Are Undergoing Combination Chemotherapy With or Without Autologous Stem Cell or Bone Marrow Transplant

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00238368
Recruitment Status : Completed
First Posted : October 13, 2005
Last Update Posted : November 6, 2017
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 17, 2007
Actual Study Completion Date : September 17, 2007